Milestone Scientific, Inc.

MLSS Healthcare Medical Instruments & Supplies

Milestone Scientific, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.0 million, up 3.99% from fiscal 2024. In the quarter to June 2026, revenue grew 22.3%, EPS grew 50.0%, free cash flow grew 66.7% and total debt fell 43.0%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

0.33 0.00 0.00%
Market cap
$29.6M
P/E
0.0×
Fwd P/E
−10.4×
Dividend yield
—
F-score
2/9
Altman Z
−22.07
Beneish M
−3.99
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

2 2 2 4
ROE
(136.47%) (132.38%) (135.39%) (121.68%)
ROA
(67.82%) (65.01%) (53.58%) (50.54%)
ROIC
(204.19%) (140.88%) (148.05%) (136.16%)
Return on Tangible Assets
(215.43%) (170.02%) (181.72%) (110.80%)
Average Days of Receivables
29.29 28.72 23.70 40.80
Free Cash Flow per Share
(0.05) (0.04) (0.02) (0.01)
Free Cash Flow
(4.22) (2.93) (1.84) (0.66)
Other line items

Show all line items

Columns are period end dates